Acme Group Official

A leading provider of CMO and R&D services to the top Indian & MNC pharmaceutical companies. The Acme group began its journey in 2005 with a bold mission of becoming a leader in the contract manufacturing space and a preferred business partner for pharmaceutical companies looking for world class capabilities and scalable operations. Guided by the founder's vision and purpose, the Acme group, over the years, has scaled new heights in the pharmaceutical value chain and today provides fully integrated contract manufacturing and development solutions to some of the top Indian and global pharmaceutical companies. These include the top 25 Indian pharmaceutical companies and 5 global MNCs. Acme strongly believes in fast growth combined with a focus on innovation and service. At present the group consists of three state-of-the-art, fast growing companies viz. Acme Formulation, Immacule and Acme Generics LLP. A Leading Pharma Group with Global Presence and approvals from EU-GMP, MHRA-UK, ANVISA Brazil, PICS Ukraine, WHO Geneva, INVIMA Colombia, USFDA through state of art of 3 facilities in North India and 1 R&D centre at Bengaluru , 1. Immacule Lifesciences- Manufacturing of Liquid and Lyophillized injections approved from MHRA, ANVISA, PICS Ukraine, USFDA . 2. Acme Formulation Pvt Ltd- Comprises of 2 blocks (General & Hormone) , manufacturing Tablets, Capsules approved by WHO Geneva,EU GMP, PERU. 3. Acme Generics LLP - Comprises of 2 blocks (General & Thyroxine) , manufacturing Tablets, Capsules approved by EU-GMP Powering the group are 2500+ highly skilled staff working in over 500,000 sq.ft manufacturing space across Northern India, producing 15 billion tablets, 3 billion capsules, 30 million ampoules and 12 million Lyo vials. The group has also expanded into niche segments of Oral Hormones, both Sex Hormones and Levothyroxine, along with General Injectables - Liquids and Lyophilized.